ADXN
Addex Therapeutics
ADXN
ADXN
4 hedge funds and large institutions have $20.4M invested in Addex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
$17.2M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
$478K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$122K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $17.2M | +$17.2M | +9,000 | New |
|
|
CC
2
Caxton Corporation
Princeton,
New Jersey
| $2.54M | – | – | – |
|
|
NLVP
3
New Leaf Venture Partners
New York
| $478K | +$478K | +2,500 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $122K | +$97.8K | +510 | +405% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$121K | -580 | Closed |
|